These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1168927)

  • 1. Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy.
    Maj J; Mogilnicka E; Przewlocka B
    Pharmacol Biochem Behav; 1975; 3(1):25-7. PubMed ID: 1168927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of theophylline and caffeine on neuroleptic-induced catalepsy.
    Maj J; Rawlów A; Sarnek J
    Pol J Pharmacol Pharm; 1976; 28(6):571-8. PubMed ID: 1034921
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy.
    Maj J; Sowińska H; Baran L
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):197-203. PubMed ID: 945050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 5-hydroxytrytamine synthesis inhibitors on neuroleptic-induced catalepsy in rats.
    Sarnek J; Baran L
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):511-6. PubMed ID: 1172422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of L-dopa on neuroleptic-induced catalepsy.
    Maj J; Kapturkiewicz Z; Sarnek J
    J Pharm Pharmacol; 1972 Sep; 24(9):735-7. PubMed ID: 4404079
    [No Abstract]   [Full Text] [Related]  

  • 6. On the anticataleptic action of cyproheptadine.
    Maj J; Sarnek J; Klimek V; Rawlów A
    Pharmacol Biochem Behav; 1976 Aug; 5(2):201-5. PubMed ID: 1033567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of antihistamine drugs on the neuroleptic-induced catalepsy.
    Pawłowski L; Sidorowicz L
    Pol J Pharmacol Pharm; 1978; 30(5):665-73. PubMed ID: 35784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic MIF analogues. Part II: Dopa potentiation and fluphenazine antagonism.
    Voith K
    Arzneimittelforschung; 1977; 27(12):2290-3. PubMed ID: 23795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narcotic antagonist potentiation of L-DOPA in the reversal of reserpine induced catalepsy.
    Namba MM; Quock RM; Malone MH
    Proc West Pharmacol Soc; 1980; 23():285-9. PubMed ID: 7190698
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible importance of 5-hydroxytryptamine in neuroleptic-induced catalepsy in rats [proceedings].
    Carter CJ; Pycock CJ
    Br J Pharmacol; 1977 Jun; 60(2):267P-268P. PubMed ID: 560233
    [No Abstract]   [Full Text] [Related]  

  • 11. FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats.
    Singh A; Naidu PS; Kulkarni SK
    Indian J Exp Biol; 2003 Nov; 41(11):1264-8. PubMed ID: 15332494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic involvement with neuroleptic catalepsy.
    Costall B; Fortune DH; Naylor RJ; Mardsen CD; Pycock C
    Neuropharmacology; 1975 Nov; 14(11):859-68. PubMed ID: 1239697
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of amantadine on motor activity and catalepsy in rats.
    Maj J; Sowińska H; Baran L
    Psychopharmacologia; 1972; 24(2):296-307. PubMed ID: 5064006
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholinergic- and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen.
    Costall B; Olley JE
    Neuropharmacology; 1971 May; 10(3):297-306. PubMed ID: 5104497
    [No Abstract]   [Full Text] [Related]  

  • 15. Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine.
    Danysz W; Gossel M; Zajaczkowski W; Dill D; Quack G
    J Neural Transm Park Dis Dement Sect; 1994; 7(3):155-66. PubMed ID: 7710668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin potentiates L-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition.
    Singh A; Naidu PS; Kulkarni SK
    Pharmacology; 2003 Jun; 68(2):81-8. PubMed ID: 12711835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of L-dopa, norepinephrine and amantadine on ulcers caused by reserpine in the rat.
    Gaetani M; Debeus R
    Digestion; 1972; 7(5):302-11. PubMed ID: 4671521
    [No Abstract]   [Full Text] [Related]  

  • 18. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfiram and the effect of catecholamines on neuroleptic-induced catalepsy in mice and rats.
    Maj J; Przegaliński E
    J Pharm Pharmacol; 1967 Jan; 19(1):68-9. PubMed ID: 4382185
    [No Abstract]   [Full Text] [Related]  

  • 20. The nucleus amygdaloideus centralis and neuroleptic activity in the rat.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1974 Feb; 25(2):138-46. PubMed ID: 4154850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.